Sinopharm Group's declining ROCE trend is concerning. Increased capital investment without matching sales suggests long-term plays. High current liabilities to total assets ratio introduces risk. These trends indicate Sinopharm may not be a multi-bagger.
$恒生指數(800000.HK)$plunge deepened unceasingly after midday. It once stumbled 620 pts or 3.9% to bottom at 15,245, hitting an over-14-month low; last at 15,320, down 545 pts or 3.4%, with a total turnover of $88.5 billion. Pharmaceuticals were sold off.$榮昌生物(09995.HK)$once collapsed 27.5% to $22.8; last at $24.9, down 21%. $三葉草生物-B(02197.HK)$nosedived 9.6% to $0.47, hitting record low.$維亞生物(01873.HK)$...
Sinopharm Group's low P/E ratio is due to investors' limited growth expectations, leading to a reduced stock price. The poor earnings outlook from analysts also contributes to its low P/E. These conditions may continue to hinder the share price.
Sinopharm Group is currently undervalued and it might be a good time to accumulate more holdings in the stock. The positive outlook on the horizon of the company's future seems not to be fully factored into the current share price.
The declining trend in Sinopharm Group's ROCE and the stock's 42% fall in the last five years doesn't inspire investor confidence. The article doesn't consider Sinopharm Group as a potential multi-bagger based on the present analysis.
$國藥控股(01099.HK)$ It's dropping just because of morgamnstanley downgrades, which at best is right 3 out of 10 times. Dont listen to these analysts which have lots of vested interest. Chinese govt has a saying, polish your knives and make the kill when opportunity comes.... This company has lots of researchers on it and stay humble without bleating data unlike western counterparts. Wont be long before a breakthrough vaccine or medicine will come through with all the resources and financial muscle it has...
$國藥控股(01099.HK)$Price will fly near (*earning release) good time and price to pick up. 股價會在年報之前起飛。這價位入場不會錯 🤑 Above are my personal point of view 以上是我個人看法
國藥控股(ADR)股票討論區
HSI Plunge Once Deepens to 620 Pts; Pharmas In Sell-off
Pharmaceuticals were sold off. $榮昌生物(09995.HK)$ once collapsed 27.5% to $22.8; last at $24.9, down 21%.
$三葉草生物-B(02197.HK)$ nosedived 9.6% to $0.47, hitting record low. $維亞生物(01873.HK)$ ...
It's dropping just because of morgamnstanley downgrades, which at best is right 3 out of 10 times. Dont listen to these analysts which have lots of vested interest. Chinese govt has a saying, polish your knives and make the kill when opportunity comes.... This company has lots of researchers on it and stay humble without bleating data unlike western counterparts. Wont be long before a breakthrough vaccine or medicine will come through with all the resources and financial muscle it has...
Stock watch ♻️
Above are my personal point of view
以上是我個人看法
Market Watch ♻️
專欄股票手錶🔰
應該很快跳漲的可能性。以批准在中東使用。
以上僅基於個人觀點。
以上基於我個人的觀點。
暫無評論